Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

被引:0
作者
Jose Vazquez
Annette C Reboli
Peter G Pappas
Thomas F Patterson
John Reinhardt
Peter Chin-Hong
Ellis Tobin
Daniel H Kett
Pinaki Biswas
Robert Swanson
机构
[1] Georgia Regents University,
[2] Cooper Medical School of Rowan University,undefined
[3] University of Alabama at Birmingham,undefined
[4] University of Texas and South Texas Veterans Health Care System,undefined
[5] Christiana Care Health Services,undefined
[6] University of California San Francisco,undefined
[7] Albany Medical Center,undefined
[8] University of Miami Miller School of Medicine and Jackson Memorial Hospital,undefined
[9] Pfizer Inc,undefined
来源
BMC Infectious Diseases | / 14卷
关键词
Anidulafungin; Azole; Candidemia; Step-down strategy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 170 条
[1]  
Pfaller MA(2007)Epidemiology of invasive candidiasis: a persistent public health problem Clin Microbiol Rev 20 133-163
[2]  
Diekema DJ(2009)International study of the prevalence and outcomes of infection in intensive care units JAMA 302 2323-2329
[3]  
Vincent JL(2003)Attributable mortality of nosocomial candidemia, revisited Clin Infect Dis 37 1172-1177
[4]  
Rello J(2005)Excess mortality, hospital stay, and cost due to candidemia: a case–control study using data from population-based candidemia surveillance Infect Control Hosp Epidemiol 26 540-547
[5]  
Marshall J(1999)Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital J Antimicrob Chemother 43 601-606
[6]  
Silva E(2009)Antimicrobial stewardship programs: how to start and steer a successful program J Manag Care Pharm 15 S18-S23
[7]  
Anzueto A(2010)Proposed changes to management of lower respiratory tract infections in response to the J Antimicrob Chemother 65 608-618
[8]  
Martin CD(2009) epidemic J Antimicrob Chemother 64 188-199
[9]  
Moreno R(2009)Outcomes of early switching from intravenous to oral antibiotics on medical wards J Manag Care Pharm 15 S12-17
[10]  
Lipman J(2006)Containing costs and containing bugs: are they mutually exclusive? BMC Infect Dis 6 94-752